Monurol Oral Granules 3G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Monurol: Oral granules (3g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Monurol 3g Pwd for Soln
Drug Image file default-drug-image.png
Monurol 3g Pwd for Soln

What is this Medicine?

FOSFOMYCIN (fos foe MYE sin) is an antibiotic. It is used to treat bacterial infections of the urinary tract.

CVS Pharmacy Patient Statistics for Monurol: Oral granules(3g)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Monurol 3g Powder for Solution

NDC: 004564300
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Cystitis, Urinary Tract Infection (UTI)

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Monurol 3g Powder for Solution

Reported Side Effects for Monurol 3g Powder for Solution

Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Enlarged Lymph Nodes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Deafness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Toxic Megacolon Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Flu Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Painful Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Optic Nerve Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
1.1-1.8%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
1.1-1.7%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
1.3-2.3%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.4%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.2%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
2.5%*
Severity: MILD
Onset: DELAYED
Menstrual Cramps Incidence:
2.6%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
3.9-10.3%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.1-5.2%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
4.5%*
Severity: MILD
Onset: EARLY
Vaginal Infection Incidence:
5.5-7.6%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
9.0-10.4%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Monurol

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.